Prevention of Progression in Chronic Liver Disease

Prevention of Progression in Chronic Liver Disease : An Update on SNMC (Stronger Neo-Minophagen C). In honour of Hans Popper's 100th birthday

Edited by  , Edited by 

Free delivery worldwide

Available. Dispatched from the UK in 3 business days
When will my order arrive?

Description

In several liver diseases, the underlying cause cannot always be eliminated, i.e. the progression of liver disease cannot be prevented. This is particularly true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40% of patients with HCV genotype 1 and up to 20% of patients with genotype 2 or 3. Several approaches are now underway to prevent or ameliorate mechanisms of disease progression. In Asia, and particularly in Japan, Glycyrrhizine-SNMC has been widely used for this purpose. At present, SNMC is under clinical evaluation in Europe.
show more

Product details

  • Hardback | 130 pages
  • 155 x 235 x 9.65mm | 830g
  • Dordrecht, Netherlands
  • English
  • 2004 ed.
  • VIII, 130 p.
  • 0792387961
  • 9780792387961

Table of contents

List of Principal Authors. Preface. Introduction; H Suzuki. 1: Mechanisms of fibrogenesis; B Stefanovic, J Lindquist, RA Rippe, B Schnabl, R Schwabe, R Bataller, DA Brenner. 2: Non-invasive markers of liver injury; V Ratziu, T Poynard. 3: Complications of cirrhosis: the relevance of hepatocellular carcinoma; M Colombo, M Iavarone. 4: Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders; S Lino. 5: Predictive parameters of non-response to standard hepatitis treatment; H Wedemeyer. 6: Concepts for the treatment of non-responders in hepatitis C; S Zeuzem. 7: Glycyrrhizin: the molecule and present knowledge of action in various liver diseases; K Shiraki, H Sato, M Kurokawa, Y Yoshida. 8: Dendritic cells in immune responses against hepatitis C virus; N Hayashi, T Kanto, T Takehara. 9: SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience; K Ikeda. 10: SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials; S Schalm, TGF van Rossum, H Orlent, BE Hansen. Index
show more